Arrowhead Pharmaceuticals, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $301.3M | $710.1M | $184.4M |
| FY2022 | $293.4M | $691.9M | $108.0M |
| FY2023 | $494.2M | $765.6M | $110.9M |
| FY2024 | $954.4M | $1.14B | $102.7M |
| FY2025 | $919.2M | $1.39B | $226.5M |